[go: up one dir, main page]

ES2551459T3 - Method to produce a supersaturated ropinirole patch - Google Patents

Method to produce a supersaturated ropinirole patch Download PDF

Info

Publication number
ES2551459T3
ES2551459T3 ES14174708.9T ES14174708T ES2551459T3 ES 2551459 T3 ES2551459 T3 ES 2551459T3 ES 14174708 T ES14174708 T ES 14174708T ES 2551459 T3 ES2551459 T3 ES 2551459T3
Authority
ES
Spain
Prior art keywords
adhesive agent
agent layer
patch
ropinirole
supersaturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14174708.9T
Other languages
Spanish (es)
Inventor
Takahito Yoshizaki
Kouji Tanaka
Kazunosuke Aida
Terumitsu Kaiho
Nobuo Tsutsumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of ES2551459T3 publication Critical patent/ES2551459T3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Método para producir un parche que comprende una capa de soporte y una capa de agente adhesivo dispuesta sobre al menos una superficie de la capa de soporte, comprendiendo el método: etapa A) obtener una composición de capa de agente adhesivo que comprende ropinirol libre en una cantidad que da como resultado del 5 al 13,2% en masa en relación con la masa total de una capa de agente adhesivo obtenida; etapa B) calentar la composición de capa de agente adhesivo a una temperatura en un intervalo de desde 50 hasta 76ºC durante de 5 minutos a 24 horas; y etapa C) enfriar la composición de capa de agente adhesivo calentada hasta temperatura normal a una velocidad promedio de disminución de temperatura de 1 a 20ºC/hora, obteniendo de ese modo la capa de 1agente adhesivo que comprende el ropinirol libre a una concentración supersaturada en forma disuelta.Method for producing a patch comprising a support layer and an adhesive agent layer disposed on at least one surface of the support layer, the method comprising: step A) obtaining an adhesive agent layer composition comprising free ropinirole in a amount resulting in 5 to 13.2% by mass relative to the total mass of a layer of adhesive agent obtained; step B) heating the adhesive agent layer composition to a temperature in a range of from 50 to 76 ° C for from 5 minutes to 24 hours; and step C) cooling the adhesive agent layer composition heated to normal temperature at an average rate of temperature decrease of 1 to 20 ° C / hour, thereby obtaining the adhesive agent layer comprising the free ropinirole to a supersaturated concentration in dissolved form.

ES14174708.9T 2013-06-28 2014-06-27 Method to produce a supersaturated ropinirole patch Active ES2551459T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013137147 2013-06-28
JP2013137147A JP5415645B1 (en) 2013-06-28 2013-06-28 Manufacturing method of patch, patch and package

Publications (1)

Publication Number Publication Date
ES2551459T3 true ES2551459T3 (en) 2015-11-19

Family

ID=50202791

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14174708.9T Active ES2551459T3 (en) 2013-06-28 2014-06-27 Method to produce a supersaturated ropinirole patch

Country Status (8)

Country Link
US (1) US9320728B2 (en)
EP (1) EP2818161B1 (en)
JP (1) JP5415645B1 (en)
KR (1) KR101516122B1 (en)
CN (1) CN104138366B (en)
CA (1) CA2855309C (en)
ES (1) ES2551459T3 (en)
TW (1) TWI488644B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101937073B1 (en) 2015-04-15 2019-01-09 히사미쓰 세이야꾸 가부시키가이샤 Transdermal patch containing ropinirole
WO2017006974A1 (en) * 2015-07-08 2017-01-12 王子ホールディングス株式会社 Transdermal-absorption-type patch
CA3010183A1 (en) 2015-12-30 2017-07-06 Corium International, Inc. Systems and methods for long term transdermal administration
AU2017281789B2 (en) 2016-06-23 2023-04-13 Corium, LLC. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
RU2764764C2 (en) 2016-07-27 2022-01-21 Кориум Интернэшнл, Инк. Transdermal memantine delivery systems
CA3032044C (en) 2016-07-27 2024-10-01 Corium Int Inc Donepezil transdermal delivery system
WO2018123822A1 (en) * 2016-12-28 2018-07-05 久光製薬株式会社 Butorphanol-containing patch
CN110300582B (en) * 2017-02-24 2022-08-02 久光制药株式会社 Adhesive and its packaging
KR102302577B1 (en) 2017-04-25 2021-09-14 히사미쓰 세이야꾸 가부시키가이샤 patch
CN110573160B (en) 2017-04-25 2022-11-18 久光制药株式会社 Adhesive
DE102018120506A1 (en) 2017-10-20 2019-04-25 Amw Gmbh Stabilized transdermal delivery system
WO2019126531A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
TW201940199A (en) * 2018-01-22 2019-10-16 日商鐘化股份有限公司 Adhesive sheet for attachment to skin

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH066534B2 (en) 1986-10-09 1994-01-26 積水化学工業株式会社 Transdermal patch
US4832953A (en) 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5308621A (en) 1991-02-18 1994-05-03 Commonwealth Scientific And Industrial Research Organisation Ascorbic acid composition and transdermal administration method
GB9511366D0 (en) 1995-06-06 1995-08-02 Smithkline Beecham Plc Novel formulations
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
US5807570A (en) 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
WO1997020550A2 (en) 1995-12-01 1997-06-12 Alza Corporation Improved method for preventing crystal formation in a dispersion of a liquid in a matrix
JP4205778B2 (en) 1998-04-17 2009-01-07 久光製薬株式会社 Patch preparation
PT1201232E (en) 1999-07-27 2007-07-24 Hisamitsu Pharmaceutical Co Patches for external use
US20040142024A1 (en) 1999-07-27 2004-07-22 Hisamitsu Pharmaceutical Co., Inc. Patch formulation for external use
DE10060550C1 (en) 2000-12-06 2002-04-18 Lohmann Therapie Syst Lts Transdermal therapeutic system for administration of oxybutynin, especially for treatment of bladder dysfunction, having two-phase matrix layer of active agent-containing droplets dispersed in adhesive
ES2559666T3 (en) 2001-03-07 2016-02-15 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
JP4792193B2 (en) 2002-08-28 2011-10-12 久光製薬株式会社 Patch
JP4354678B2 (en) 2002-08-28 2009-10-28 久光製薬株式会社 Patch
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
DE10261696A1 (en) * 2002-12-30 2004-07-15 Schwarz Pharma Ag Device for the transdermal administration of rotigotine base
WO2005115355A1 (en) 2004-05-28 2005-12-08 Hisamitsu Pharmaceutical Co., Inc. Pasting preparation
JP5075334B2 (en) 2004-11-22 2012-11-21 久光製薬株式会社 Drug-containing patch
GB0524961D0 (en) 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents for systemic effect
JP5243254B2 (en) * 2006-10-11 2013-07-24 久光製薬株式会社 Crystal-containing patch
US20080226698A1 (en) 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
EP2255802B1 (en) 2008-02-27 2018-01-17 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
ES2778724T3 (en) 2008-02-27 2020-08-11 Hisamitsu Pharmaceutical Co Patch
CN102361639A (en) 2009-04-24 2012-02-22 久光制药株式会社 Adhesive patch-containing package bag and method for storing adhesive patch
KR101292768B1 (en) * 2010-04-23 2013-08-05 아이큐어 주식회사 Transdermal Drug Delivery System
WO2011136283A1 (en) 2010-04-28 2011-11-03 久光製薬株式会社 Skin irritation suppressant and transdermal preparation
KR101844625B1 (en) 2011-05-31 2018-04-02 히사미쓰 세이야꾸 가부시키가이샤 Ropinirole-containing adhesive patch and packaging therefor
KR101848961B1 (en) * 2011-05-31 2018-04-13 히사미쓰 세이야꾸 가부시키가이샤 Ropinirole-containing adhesive skin patch and packaged product thereof
US9849095B2 (en) * 2011-12-01 2017-12-26 Teikoku Seiyaku Co., Ltd. Ropinirole-containing adhesive patch
JP5270035B1 (en) 2012-12-06 2013-08-21 久光製薬株式会社 Patch and method for producing the same
JP5307931B1 (en) 2012-12-27 2013-10-02 久光製薬株式会社 Patch and method for producing the same

Also Published As

Publication number Publication date
US20150004215A1 (en) 2015-01-01
KR20150002491A (en) 2015-01-07
US9320728B2 (en) 2016-04-26
CA2855309A1 (en) 2014-10-16
JP2015010066A (en) 2015-01-19
CN104138366A (en) 2014-11-12
TW201446268A (en) 2014-12-16
CN104138366B (en) 2016-05-11
EP2818161A1 (en) 2014-12-31
EP2818161B1 (en) 2015-10-07
CA2855309C (en) 2015-02-17
KR101516122B1 (en) 2015-04-29
TWI488644B (en) 2015-06-21
JP5415645B1 (en) 2014-02-12

Similar Documents

Publication Publication Date Title
ES2551459T3 (en) Method to produce a supersaturated ropinirole patch
CO2019002744A2 (en) Water soluble compositions comprising purified cannabinoids
MX2017017172A (en) BINDING-ACTIVE PRINCIPLE CONJUGATES (ADCS) AND BINDING-PROFARMACO CONJUGATES (APDCS) WITH ENZYMATICALLY SCINDIBLE GROUPS.
CO2017008082A2 (en) Microstructure using cross-linked hyaluronic acid hydrogel and method to prepare the same
AR098191A1 (en) APPARATUS FOR HEATING FUMABLE MATERIAL
AR088558A1 (en) SYSTEM THAT GENERATES AEROSOL WITH IMPROVED CONTROL OF AEROSOL PRODUCTION
BR112017023516A2 (en) fiber reinforced polymer composition; and article.
MX2016000349A (en) Photovoltaic-thermal solar energy collection system with energy storage.
CL2017001377A1 (en) A new crystalline form of a benzimidazole derivative and a method of preparation thereof
ES2722207T3 (en) Procedures for cryopreservation of retinal pigment epithelial cells derived from cytoblasts grown on a polymeric substrate
MX2016003123A (en) Battery thermal management systems, apparatuses, and methods.
MX362375B (en) A whole, leech saliva extract.
BR112014014376A2 (en) substrate with a structured surface and methods for its production, and methods for determining its wetting properties
BR112015017427A2 (en) article comprising a polymeric substrate and a silicone polymer layer
AR102563A1 (en) DENSIFIED COMPOSITION FOR THE TREATMENT OF A UNDERGROUND FORMATION
BR112015017500A2 (en) optoelectronic device and method to produce the same
MX2015012444A (en) METHODS OF DIAGNOSIS, SELECTION AND TREATMENT OF DISEASES AND AFFECTIONS CAUSED BY OR ASSOCIATED WITH METHANOGENS.
AR098704A1 (en) FROZEN CONFITTERY PRODUCT WITH AN EASILY DISPOSABLE GEL COVER AND A METHOD FOR MANUFACTURING THE SAME
BR112017017096A2 (en) " method of making nano metal coil "
MX2017001645A (en) 3-phenyl-benzofuran-2-one diphosphite derivatives as stabilizers.
BR112016014305A2 (en) GEL HANDKEEPS AND METHOD FOR MANUFACTURING A GEL HANDKEEPER
CL2013001071A1 (en) Method for sintering a composition comprising two components in powder form, where the water activity of the first component is higher than that of the second, which comprises heating at a temperature higher than the glass transition temperature of the first component but lower than that of the second .
MX2016015092A (en) Cancer stem cell proliferation inhibitor.
MX389168B (en) PROCEDURE FOR PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS.
MX2015009390A (en) METHOD OF PRODUCTION OF BETA-CASEINA COMPOSITIONS AND RELATED PRODUCTS.